286 related articles for article (PubMed ID: 17380399)
1. Cryoglobulinemia related to hepatitis C virus infection.
Dore MP; Fattovich G; Sepulveda AR; Realdi G
Dig Dis Sci; 2007 Apr; 52(4):897-907. PubMed ID: 17380399
[TBL] [Abstract][Full Text] [Related]
2. [Current therapeutic strategies for HCV-associated cryoglobulinemia].
Iannuzzella F; Garini G
Reumatismo; 2008; 60(3):163-73. PubMed ID: 18854876
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Delluc A; Piette JC; Cacoub P
Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
Garini G; Allegri L; Vaglio A; Buzio C
Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
[TBL] [Abstract][Full Text] [Related]
5. HCV infection: pathogenesis, clinical manifestations and therapy.
Antonelli A; Ferri C; Galeazzi M; Giannitti C; Manno D; Mieli-Vergani G; Menegatti E; Olivieri I; Puoti M; Palazzi C; Roccatello D; Vergani D; Sarzi-Puttini P; Atzeni F
Clin Exp Rheumatol; 2008; 26(1 Suppl 48):S39-47. PubMed ID: 18570753
[TBL] [Abstract][Full Text] [Related]
6. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
Benstead TJ; Chalk CH; Parks NE
Cochrane Database Syst Rev; 2014 Dec; (12):CD010404. PubMed ID: 25525951
[TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.
Saadoun D; Landau DA; Calabrese LH; Cacoub PP
Rheumatology (Oxford); 2007 Aug; 46(8):1234-42. PubMed ID: 17566058
[TBL] [Abstract][Full Text] [Related]
9. Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24.
Saadoun D; Resche Rigon M; Thibault V; Longuet M; Pol S; Blanc F; Pialoux G; Karras A; Bazin-Karra D; Cazorla C; Vittecoq D; Musset L; Decaux O; Ziza JM; Lambotte O; Cacoub P
Ann Rheum Dis; 2014 May; 73(5):831-7. PubMed ID: 23606708
[TBL] [Abstract][Full Text] [Related]
10. Extrahepatic immunological complications of hepatitis C virus infection.
Vassilopoulos D; Calabrese LH
AIDS; 2005 Oct; 19 Suppl 3():S123-7. PubMed ID: 16251807
[TBL] [Abstract][Full Text] [Related]
11. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Lunel F; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
[TBL] [Abstract][Full Text] [Related]
12. Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.
Mazzaro C; Zorat F; Caizzi M; Donada C; Di Gennaro G; Maso LD; Carniello G; Virgolini L; Tirelli U; Pozzato G
J Hepatol; 2005 May; 42(5):632-8. PubMed ID: 15826710
[TBL] [Abstract][Full Text] [Related]
13. New insights in cryoglobulinemic vasculitis.
Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
[TBL] [Abstract][Full Text] [Related]
14. Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.
Himoto T; Masaki T
Clin Dev Immunol; 2012; 2012():871401. PubMed ID: 22988469
[TBL] [Abstract][Full Text] [Related]
15. Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
Saadoun D; Resche Rigon M; Sene D; Terrier B; Karras A; Perard L; Schoindre Y; Coppéré B; Blanc F; Musset L; Piette JC; Rosenzwajg M; Cacoub P
Blood; 2010 Jul; 116(3):326-34; quiz 504-5. PubMed ID: 20439619
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
[TBL] [Abstract][Full Text] [Related]
18. [Cryoglobulinemia].
Cacoub P; Sène D; Saadoun D
Rev Med Interne; 2008 Mar; 29(3):200-8. PubMed ID: 18242787
[TBL] [Abstract][Full Text] [Related]
19. PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
Saadoun D; Resche Rigon M; Pol S; Thibault V; Blanc F; Pialoux G; Karras A; Bazin-Kara D; Cazorla C; Vittecoq D; Musset L; Peltier J; Decaux O; Ziza JM; Lambotte O; Cacoub P
J Hepatol; 2015 Jan; 62(1):24-30. PubMed ID: 25135864
[TBL] [Abstract][Full Text] [Related]
20. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
Roccatello D; Fenoglio R; Sciascia S
Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]